Davis Aaron I. - 01 Jun 2022 Form 4 Insider Report for Rain Therapeutics Inc.

Role
Director
Signature
/s/ Nelson Cabatuan, Attorney-in-fact for Aaron I. Davis
Issuer symbol
N/A
Transactions as of
01 Jun 2022
Net transactions value
$0
Form type
4
Filing time
19 Aug 2022, 17:40:57 UTC
Previous filing
11 May 2022
Next filing
28 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RAIN Stock Option (Right to Buy) Award $0 +20,000 $0.000000 20,000 01 Jun 2022 Common Stock 20,000 $2.44 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 20,000 shares of the Issuer's common stock, which will vest in full on June 1, 2023, subject to the Reporting Person's continued service to the Issuer.